Olmetec Plus

Olmetec Plus

olmesartan + hydrochlorothiazide

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Per 20/12.5 mg tab Olmesartan medoxomil 20 mg, hydrochlorothiazide 12.5 mg. Per 40/12.5 mg tab Olmesartan medoxomil 40 mg, hydrochlorothiazide 12.5 mg
Indications/Uses
Essential HTN in patients whose BP is not adequately controlled on olmesartan medoxomil or hydrochlorothiazide alone.
Dosage/Direction for Use
Administration
May be taken with or without food.
Contraindications
Severe renal impairment, refractory hypokalaemia, hypercalcaemia, cholestasis & biliary obstructive disorders, anuria. Pregnancy (2nd & 3rd trimesters), lactation.
Special Precautions
Intravascular vol depletion, conditions w/ stimulation of the renin-angiotensin-aldosterone system, renovascular HTN, renal & hepatic impairment, kidney transplantation, aortic & mitral valve stenosis, obstructive hypertrophic cardiomyopathy, primary aldosteronism, metabolic & endocrine effects, electrolyte imbalance, ischaemic heart disease or ischaemic cerebrovascular disease.
Drug Interactions
Drugs that affect K levels, other antihypertensives, NSAIDs, alcohol, barbiturates, narcotics, antidepressants, baclofen, amifostine, cholestyramine & colestipol resins, anticholinergics, lithium, digitalis glycosides, antidiabetic agents, metformin, β-blockers, diazoxide, pressor amines, nondepolarizing skeletal muscle relaxants, sulfinpyrazone, allopurinol, Ca salts, amantadine, cyclophosphamide, MTX.
MIMS Class
Angiotensin II Antagonists
ATC Classification
C09DA08 - olmesartan medoxomil and diuretics ; Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
Presentation/Packing
Form
Olmetec Plus 20/12.5 mg FC tab
Packing/Price
3 × 10's
Form
Olmetec Plus 40/12.5 mg FC tab
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in